MCAZ

Circulars

CIRCULAR 5 OF 2023 -INSTRUCTION TO QUARANTINE TETRACYCLINE HYDROCHLORIDE OPHTHALMIC OINTMENT USP 1% MANUFACTURED BY GALENTIC PHARMA (INDIA) PVT, LTD, R-673, T.T.C.  MIDC RABALE, THANE-BELAPUR ROAD, NAVI MUMBAI-400701, MAHARASHTRA, INDIA
CIRCULAR 5 OF 2023 -INSTRUCTION TO QUARANTINE TETRACYCLINE HYDROCHLORIDE OPHTHALMIC OINTMENT USP 1% MANUFACTURED BY GALENTIC PHARMA (INDIA) PVT, LTD, R-673, T.T.C. MIDC RABALE, THANE-BELAPUR ROAD, NAVI MUMBAI-400701, MAHARASHTRA, INDIA
Size: 587kb
Circular 4 of 2023 – Change of Value Added Tax (TAX) Rate from 14.5% to 15%
Circular 4 of 2023 – Change of Value Added Tax (TAX) Rate from 14.5% to 15%
Size: 189KB
Circular 02 of 2023- Renewal of Premises and Persons Licences
Circular 02 of 2023- Renewal of Premises and Persons Licences
Size: 511
Circular 01 of 2023- Renewal of Permits and Persons licences for Wholesale dealers, Sales Representative and Pharmacy Technicians
Circular 01 of 2023- Renewal of Permits and Persons licences for Wholesale dealers, Sales Representative and Pharmacy Technicians
Size: 539KB
Circular 24 of 2022- Importation of Medicines
Circular 24 of 2022- Importation of Medicines
Size: 894KB
Circular 23 of 2022- Importation of Medicines
Circular 23 of 2022- Importation of Medicines
Size: 1024BK
MCAZ Circular 20 of 2022 CBD products clarification
MCAZ Circular 20 of 2022 CBD products clarification
Size: 604KB
Invitation to stakeholders meetings
Invitation to stakeholders meetings
Size: 254KB
Circular 19 of 2022 – Fees Schedule
Circular 19 of 2022 – Fees Schedule
Size: 645KB
Published: September 19, 2022
Circular 16 of 2022 Publication of Cancelled Wholesale Dealers’ Permit, Premises and Persons’ Licences.
Circular 16 of 2022 Publication of Cancelled Wholesale Dealers’ Permit, Premises and Persons’ Licences.
Size: 2MB

 1,276 total views

Circulars

CIRCULAR 5 OF 2023 -INSTRUCTION TO QUARANTINE TETRACYCLINE HYDROCHLORIDE OPHTHALMIC OINTMENT USP 1% MANUFACTURED BY GALENTIC PHARMA (INDIA) PVT, LTD, R-673, T.T.C.  MIDC RABALE, THANE-BELAPUR ROAD, NAVI MUMBAI-400701, MAHARASHTRA, INDIA
CIRCULAR 5 OF 2023 -INSTRUCTION TO QUARANTINE TETRACYCLINE HYDROCHLORIDE OPHTHALMIC OINTMENT USP 1% MANUFACTURED BY GALENTIC PHARMA (INDIA) PVT, LTD, R-673, T.T.C. MIDC RABALE, THANE-BELAPUR ROAD, NAVI MUMBAI-400701, MAHARASHTRA, INDIA
Size: 587kb
Circular 4 of 2023 – Change of Value Added Tax (TAX) Rate from 14.5% to 15%
Circular 4 of 2023 – Change of Value Added Tax (TAX) Rate from 14.5% to 15%
Size: 189KB
Circular 02 of 2023- Renewal of Premises and Persons Licences
Circular 02 of 2023- Renewal of Premises and Persons Licences
Size: 511
Circular 01 of 2023- Renewal of Permits and Persons licences for Wholesale dealers, Sales Representative and Pharmacy Technicians
Circular 01 of 2023- Renewal of Permits and Persons licences for Wholesale dealers, Sales Representative and Pharmacy Technicians
Size: 539KB
Circular 24 of 2022- Importation of Medicines
Circular 24 of 2022- Importation of Medicines
Size: 894KB
Circular 23 of 2022- Importation of Medicines
Circular 23 of 2022- Importation of Medicines
Size: 1024BK
MCAZ Circular 20 of 2022 CBD products clarification
MCAZ Circular 20 of 2022 CBD products clarification
Size: 604KB
Invitation to stakeholders meetings
Invitation to stakeholders meetings
Size: 254KB
Circular 19 of 2022 – Fees Schedule
Circular 19 of 2022 – Fees Schedule
Size: 645KB
Published: September 19, 2022
Circular 16 of 2022 Publication of Cancelled Wholesale Dealers’ Permit, Premises and Persons’ Licences.
Circular 16 of 2022 Publication of Cancelled Wholesale Dealers’ Permit, Premises and Persons’ Licences.
Size: 2MB
Circular-15-of-2022-Safety-measures-for-sodium-valproate-and-the-risk-of-congenital-malformations-in-neonates-and-neurodevelopmental-disorders-in-children-exposed-to-sodium-valproate-during-pregnancy
Circular-15-of-2022-Safety-measures-for-sodium-valproate-and-the-risk-of-congenital-malformations-in-neonates-and-neurodevelopmental-disorders-in-children-exposed-to-sodium-valproate-during-pregnancy
Size: 156MB
Published: July 25, 2022
Circular 13 of 2022 Pharmacovigilance system requirements for Pharmaceutical Industry
Circular 13 of 2022 Pharmacovigilance system requirements for Pharmaceutical Industry
Size: 289KB
Circular 11 of 2022 Revised MCAZ Clinical Trial Guidelines
Circular 11 of 2022 Revised MCAZ Clinical Trial Guidelines
Size: 996KB
Published: May 20, 2022
Circular 9 of 2022 Inspection of Premises prior to renewal of Licences and Permits
Circular 9 of 2022 Inspection of Premises prior to renewal of Licences and Permits
Size: 38KB
Published: March 31, 2022
Circular 8 of 2022 -Publication of Cancelled Wholesale Dealers’ Permit and Persons’ Licences
Circular 8 of 2022 -Publication of Cancelled Wholesale Dealers’ Permit and Persons’ Licences
Size: 880KB
Published: March 18, 2022
circular 06 of 2022- Renewal of Wholesale Dealers
circular 06 of 2022- Renewal of Wholesale Dealers
Circular 02 of 2022- Renewal of Pharmacies
Circular 02 of 2022- Renewal of Pharmacies
Size: 490kb
Circular 3 of 2022 – Clarification of Conditions for Medicines Registration Requirements and Subsequent Expansion of Registration Certificate, Section 15 Format Annexure
Circular 3 of 2022 – Clarification of Conditions for Medicines Registration Requirements and Subsequent Expansion of Registration Certificate, Section 15 Format Annexure
Size: 118KB
Annex1-Template-for-comments-on-Draft-Guideline-for-market-Authorization-Renewal
Annex1-Template-for-comments-on-Draft-Guideline-for-market-Authorization-Renewal
Size: 25 KB
DRAFT GUIDELINES FOR MARKET AUTHORISATION RENEWALS
DRAFT GUIDELINES FOR MARKET AUTHORISATION RENEWALS
Size: 195 KB
Circular 5 of 2022 – Publication of Cancelled Premises and Persons’ Licences.
Circular 5 of 2022 – Publication of Cancelled Premises and Persons’ Licences.
Size: 859KB
Circular 16 of 2021  –  Use of Ivermectin human oral formulations for prevention and or treatment of COVID 19
Circular 16 of 2021 – Use of Ivermectin human oral formulations for prevention and or treatment of COVID 19
Size: 62KB
Circular 1 of 2022 – Publication of product Information for Registered medicinal Products (Summary of Product Characteristics
Circular 1 of 2022 – Publication of product Information for Registered medicinal Products (Summary of Product Characteristics
Size: 271KB
Circular 4 of 2020 – Preventive Measures to Reduce the Spread of COVID-19 (Coronavirus) by the Medicines Control Authority of Zimbabwe (MCAZ)
Circular 4 of 2020 – Preventive Measures to Reduce the Spread of COVID-19 (Coronavirus) by the Medicines Control Authority of Zimbabwe (MCAZ)
Published: April 5, 2021
Circular 3 of 2020-Renewal of Premises Licences- Pharmacies
Circular 3 of 2020-Renewal of Premises Licences- Pharmacies
Published: April 5, 2021
Circular 6 of 2020 – Grace period for renewal of wholesale dealer’s permit 
Circular 6 of 2020 – Grace period for renewal of wholesale dealer’s permit 
Size: 551 KB
Published: July 9, 2020

 3,824 total views